Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Q4 2020 Earnings Call
Company Participants
FINAL

Derek Bulas, Assistant Vice President, Legal
Jennifer Allen, Vice President & Chief Financial Officer
V. Prem Watsa, Chairman & Chief Executive Officer

Other Participants
Alan Parsow, Analyst
Jaeme Gloyn, Analyst
Jeff Fenwick, Analyst
Junior Ra, Analyst
Mark Dwelle , Analyst
Tom MacKinnon, Analyst
Unidentified Participant

Bloomberg Transcript

Presentation
Operator
Good morning and welcome to Fairfax 2020 Year End Results Conference Call. Your lines
have been placed in a listen-only mode. After the presentation, we will conduct a
question-and-answer session. (Operator Instructions) Today's conference is being
recorded. If you have any objection you may disconnect at this time.
Your host for today's call is Prem Watsa with opening remarks from Mr. Derek Bulas. Mr.
Bulas, please begin.

Derek Bulas
Good morning and welcome to our call to discuss Fairfax's 2020 year-end results.
This call may include forward-looking statements. Actual results may differ perhaps
materially from those contained in such forward-looking statements as a result of a variety
of uncertainties and risk factors. The most foreseeable of which are set out under risk
factors in our Base Shelf Prospectus, which has been filed with Canadian Securities
Regulators and is available on SEDAR, and which now include the risk of adverse
consequences to Fairfax's business, investments, and personnel resulting from or related
to the COVID-19 pandemic. Fairfax disclaims any intention or obligation to update or
revise any forward-looking statements, except as required by applicable securities law.

Page 1 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

I'll now turn the call over to our Chairman and CEO, Prem Watsa.

V. Prem Watsa

{BIO 1433188 <GO>}

FINAL

Thank you, Derek. Good morning, ladies and gentlemen, welcome to Fairfax's 2020 yearend conference call. I plan to give you some of the highlights and then pass the call to Jen
Allen, our Chief Financial Officer for additional financial and accounting details.
2020, as all of you know, was an unprecedented year. I'm not sure many of us would
believe when we left our offices last March that almost a year later we would still be
dealing with this pandemic to this degree. But we can see the light at the end of the
tunnel as multiple vaccines now exist and testing has improved significantly.

Bloomberg Transcript

A majority of our employees worldwide have worked from home for most of 2020, not
missing a beat. I wanted to again thank all our employees all over the world who have
been fully committed over this period to provide outstanding service to our customers. I
am very grateful to all of them. The vaccine is being given now all over the world. We
expect this to come to an end and we expect to return to normalcy soon.
Coming to our results, Fairfax's net earnings were $218 million in 2020 versus $2 billion in
2019, which equates to net earnings per diluted share of $6.29 in 2020 versus $69.79 in
2019. Under the circumstances, we are very pleased about our performance in 2020
which was a real light stress test. Fairfax's book value per share in 2020 increased by
0.6%, basically flat adjusted for the $10 per share common dividend paid in the first
quarter of 2020 was $478 per share. We had earnings in 2020 of $218 million as I've said,
reflecting the effects of the pandemic on both our underwriting and investment results.
Our net loss on investments of approximately $1.5 billion at the end of the first quarter
completely reversed and we finished 2020 with net gains of $313 million, an increase of
$1.8 million. In 35 years, we've never experienced swings in the stock prices like we did in
2020. Our float increased by 8% in 2020 to $24.3 billion and our float per share increased
by 11% to $927 per share.
Our Insurance and reinsurance companies produced a consolidated combined ratio of
97.8% for the year, which included catastrophe losses of $644 million or 4.7 combined
ratio points and COVID-19 losses of $669 billion or 4.8 combined ratio points. Excluding
COVID-19 losses, the consolidated combined ratio was 93% with 12.5% growth in gross
premiums written on the back of a strong pricing environment.
In the fourth quarter, total [ph] gross premiums were up 16%. We had some significant
growth in gross premiums as Allied World was up 22% for the year, 26% for the fourth
quarter; Odyssey 15% for the year, 24% for the fourth quarter; and Northbridge 14% for
the year, 22% for the fourth quarter. All of our major insurance companies with the
exception of Brit generated combined ratios of less than 100%, that's despite
unprecedented times and included a high frequency of catastrophes and a global
pandemic. More on this from Jen Allen.

Page 2 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

FINAL

In 2020, we booked net COVID losses, as I said of $669 million across all of our
companies. Of this, approximately 35% comes from business interruption exposures
primarily outside the United States and about 34% comes from event cancellation
coverages, and balance comes from areas such as casualty, surety and travel lines.
On a gross basis, approximately 60% of our COVID provisions are in IBNR (Technical
Difficulty) paid losses are about 20% and case reserves make up the remaining 20%. As
you can see, there is still considerable uncertainty as to the ultimate cost of the virus. The
IBNR estimates may prove excessive in some of our companies, and they may not be
enough in others. In addition, as we are all well aware, pandemic is ongoing. As long as it
persists and disrupts the economy, new losses may emerge.
The size of the ultimate loss will also depend to some extent on various court outcomes
as litigation has been filed in many jurisdictions. All in all, we remain comfortable with the
provisions we have made to date in the context of the current market environment. Our
reserves, of course, remained strong with consolidated redundancies in our insurance and
reinsurance operations in 2020 of $435 million or 3.3% of the premiums.
Our insurance businesses in many parts of the world are seeing price increases anywhere
from 10% to 30%, and terms are tightening. Prospects of our insurance business are
excellent and we think we are in a hard market and well positioned to expand significantly.

Bloomberg Transcript

Last quarter, I mentioned our excitement about Ki, a standalone business begun by Brit,
the first fully-digital follow-on syndicate at Lloyd's. It is doing very well.
I should also mention that Digit, a fully digital insurance company in India run by Kamesh
Goyal had another year of exceptional growth. In three years, it has grown from a start-up
providing an excess of 400 million and is expected to be profitable, including investment
income for the year ended March 31, 2021. Digit raised $25 million from private equity
investors at $1.9 billion at end year '20 that continues to be valued on our books at $0.9
billion and we don't expect any changes. Of course, that's on a 100% basis. Also the
Indian budget allowed us to go to 74% from 49%.
For the year, operating income was strong at $916 million. Net gains on investment for the
year was $313 million with losses on net equity exposures of $137 [ph] million offset by net
gains on bonds. The net losses on equities included losses on our last remaining short
position which is finally closed at the end of the year, partially offset by net gains of Stelco,
BlackBerry convertible and the Asian Value Fund. As mentioned in our 2019 Annual Report,
we will never short stock indices or individual companies again.
Net gains on our bond portfolio was $562 million, primarily on our corporate bonds that
were purchased in the first and second quarters of 2020. As we have mentioned in our
annual meetings and in our annual reports, quarterly reports with IFRS accounting, where
stocks and bonds are recorded at that market subject to mark-to-market gains or losses
quarterly and annual income will fluctuate, and investment results will only make sense
over the longer term.

Page 3 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

FINAL

In the first quarter of 2020, we had a negative 3.6% return on our investment portfolio.
And by the end of the year, our investment returns more than reversed and we ended
the year with a positive return of 2.7%. I have previously highlighted this to you, but will do
it once more, if you look at Page 188 of our 2019 annual report last column shows the
annual total return on our investment portfolio for the last 34 years. We'll update it of
course for 2020.
There were four years when we had a negative investment return. In each case, we
rebounded significantly. From that table in 1990, we had a 4.4% negative return; 1991, the
following year, up 14.6%; 1999 negative return 2.7%; 2000, the following year, up 12.2%;
2013 negative 4.3%; 2014 up 8.6%; 2016 negative 2.2%; 2017, 6.8%. So that was only four
times in 34 years. Each time investors worried about our investments, each time
investment results were much better than they expected. This time our investments have
rebounded more quickly. Our history had shown that returns are very lumpy, and this has
worked for us over the last 35 years. We have never focused on steady quarterly
earnings.

Bloomberg Transcript

As I've said previously, long-term value investing has gone through a very difficult time for
many years now. Valuations of value-oriented stocks versus growth stocks, particularly
technology, had never been so extreme, exceeding even the extremes of the dot-com
era in 2000. As the economy normalizes, we expect a reversion to the main and valueoriented stocks coming to the fall.
After the Pfizer vaccine was announced in early November 2020, we started to see this
taking place. Two examples very quickly may make it clearer for you. Fairfax India was
selling at $6.80 per share at the end of the third quarter, while its book value was more
than $16 per share. Today, it's up to $12.40 per share, means like only a matter of time.
Therefore, Fairfax India exceeds this 2020 high and does exceptionally well as the Indian
economy recovers from COVID-19. The Indian government came out with an exceptionally
business-friendly budget recently. Atlas Corp. was another one that I mentioned to you
run by David Sokol and Bing Chen closed 2019 at $14 per share went down to $6.30 per
share in March. Today it's at $12.70 per share. Atlas is financially very strong, has great
management and we think it's only a matter of time before it exceeds its previous high.
We expect a significant return on our stock portfolio, as the economy continues to
normalize.
In November, Fairfax and Allied World entered into an agreement with Cornell Capital and
Hudson Structured Capital to sell its majority ownership interest in Vault Insurance. We will
continue to own a 10% stake in Vault following the sale. Scott Carmilani was instrumental in
creating and growing Vault and has pivoted from his role with Fairfax to the Chairman of
the Board of Vault. Closing of this transaction is subject to various regulatory approvals
expected to occur in the first quarter of 2021. We are very grateful to Scott for all his
contribution to Fairfax, especially at Allied World, the company which he led from being a
start-up becoming an industry-leading and highly successful worldwide insurance and
reinsurance business.
In December, Fairfax Africa completed its previously announced transaction with Helios
Holdings and was renamed Helios Fairfax Partners, and continues to be listed on the
Page 4 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

FINAL

Toronto Stock Exchange. Helios Holdings has been investing successfully in Africa for over
15 years. We are very excited about this transaction and look forward to our partnership
with Tope and Baba, the Co-founders of Helios Holdings.
Also, in December, we entered into an agreement with CVC Capital Partners, whereby
CVC will acquire 100% of RiverStone Barbados, our European runoff operation. OMERS,
our partner will also sell its 40% interest as part of the transaction. On closing, we expect
to receive proceeds of approximately $730 million for a 60% interest in RiverStone
Barbados, and a contingent value note for potential future proceeds of up to $236 million,
should certain returns we met. Part of the agreement, the company entered into an
agreement with RiverStone Barbados to purchase unless sold earlier certain investments
and the equity investments owned by RiverStone Barbados at a fixed price of
approximately $1.2 billion prior to December '22. So, we have two years to buy this.

Bloomberg Transcript

Closing of this transaction is subject to various regulatory approvals. We would like to
thank Lufthansa [ph] and all the employees at Riverstone Barbados and wish them the
very best in the future. Subsequent to 2020, Fairfax entered into an agreement with
OMERS, pursuant into which OMERS will acquire a 14% interest in Brit Limited. Cash
purchase price for this investment is approximately $375 million. The transaction is subject
to customary closing conditions, and is expected to close in the second quarter of 2021.
We have set for some time that we wanted to monetize many of our investments,
including particularly many of our private investments. Here's what we've done in 2020.
We merged Dexterra with Horizon North for a 49% ownership in the public company. We
now have a company which we expect will have a $1 billion in revenue and $100 million in
EBITDA for a few years -- in a few years. We sold the Davos for $59 million with an
additional earnout overtime, which should result in a 100% return on our capital
investment. Peak performance agreed to sell its Easton Baseball operation to Rawlings for
shares and cash at the significant profit for us and our partner, Power Core. And I have just
mentioned, we completed the merger of Fairfax Africa with Helios Holdings for a 32%
ownership in the combined entity.
This is just the beginning. Various initiatives are underway including taking some of our
other private investments public. Farmers Edge recently announced that it was going
public in the first quarter of 2021. We continued to have approximately $1.3 billion at the
holding company predominantly in cash and short-term securities. Please note that our
cash in the holding company is to meet any and every contingency that Fairfax might face
in this uncertain time period. We're not making any long-term investments with this cash
other than to support our insurance and reinsurance operations.
The closing of the RiverStone Barbados transaction which is expected to be in the first
quarter, we expect to have $1 billion of cash and investments at the holding company with
our credit facility fully paid off. In December 2020, the company's insurance and
reinsurance companies held approximately $16 billion in cash and short-term securities
representing approximately 38% of our portfolio investments, comprising of $13 billion of
subsidiary cash and short-term investments and $2.9 billion of short-dated U.S. treasuries.
Our investment portfolios will be largely unimpacted by rising interest rates as we have
not reached the yield. In fact, we will benefit from rising investment income.
Page 5 of 21



FINAL

Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

We have recently begun investing as you know with Kennedy Wilson in first mortgages for
the term less than five years. With the run rate at the end of 2020 of approximately $19
billion in gross premiums and our insurance subsidiaries expected to grow significantly in
the next few years, a huge focus on underwriting discipline, a portfolio of over $40 billion
and HWIC operating in a stock pickers market, all grounded on our fair and friendly culture
built over 35 years, we expect to be firing on all cylinders in 2021 and beyond. In the past
35 year, we've had years when our book value has grown by 40% to 50% and our stock
price has increased by a 130%. We expect to reward you our shareholders for your
patience. We feel the best is yet to come.
I will now pass the call over to Jen Allen, our Chief Financial Officer. Jen?

Jennif er Allen

{BIO 20542595 <GO>}

Bloomberg Transcript

Thank you, Prem. We wanted to let you know that in addition to the press release that was
issued yesterday on our year-end results, Fairfax's 2020 annual report will be posted on
the company's website on March 5, 2021. I wanted to also take a moment and thank all of
our employees globally. We've been faced with many challenges through 2020, but each
finance team showed their resilience and commitment to Fairfax. A huge thank you for all
your efforts. You should all be very proud of your accomplishments.
Now looking to our results. In the fourth quarter of 2020, the effects from the COVID-19
pandemic on the global financial markets started to reverse with significant improvements
noted in the equity markets, which benefited Fairfax's fourth quarter results. Our core
underwriting performance continued to be very strong, despite higher catastrophe losses
in 2020 and the reported COVID-19 losses.
I'll start with a few key highlights from our 2020 results. We reported strong underwriting
performance with an underwriting profit of $309 million, that represented a combined
ratio of 97.8% which was achieved despite COVID-19 losses and higher catastrophe
losses. Our net gains on investments were $313 million for 2020 with over $1.2 billion in
net gains on investments been recorded in the fourth quarter. And finally, we ended the
year with a consolidated balance sheet position for our investments and associates with
fair values exceeding the carrying values by $712 million. That represented on a pre-tax
and non-controlling interest basis appreciation of approximately $1.1 billion since March 31,
2020, which is not reflected in our book value per share as these investments are equity
accounted.
Taking the above key highlights into account, Fairfax reported net earnings of $218 million
or $6.29 per share on a fully diluted basis in 2020 compared to 2019 when we reported
net earnings of $2 billion or $69.79 per share on a fully diluted basis.
Looking in more detail to the results of our underlying reporting segments, starting with
our ongoing insurance and reinsurance operations. As noted, our core underwriting
performance continued to be very strong with underwriting profit at our insurance and
reinsurance operations in 2020 of $309 million and a combined ratio below 100% at

Page 6 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Bloomberg Transcript

FINAL

97.8%, which compared to an underwriting profit of $395 million and a combined ratio of
96.9% in 2019.
Underwriting performance in 2020 remained strong, despite COVID-19 losses of $669
million and catastrophe losses of $644 million, which were higher than 2019 by $147
million. Despite those COVID-19 losses and additional catastrophe losses, in aggregate
that were $815 million, Fairfax still achieved an underwriting profit of $309 million and a
combined ratio of 97.8% or 93.0% adjusted for those COVID-19 losses. All of our
insurance and reinsurance companies achieved combined ratios below 100% in 2020,
with the exception of Brit primarily as a result of the impact of COVID-19 losses.
Overview of our core underwriting results for 2020 are as follows: Northbridge reported a
combined ratio of 92.4% and underwriting profits of $109 million, which was an
underwriting improvement of $62 million from 2019; Odyssey Group reported an
underwriting profit of $190 million with a combined ratio of 94.7%, an underwriting
improvement over 2019 of $100 million; Crum & Forster reported an underwriting profit of
$60 million and a combined ratio of 97.5%, which was relatively consistent with their 2019
results; Zenith National reported lower underwriting profits of $52 million and a combined
ratio of 91.9%, which reflected price decreases and lower payroll exposure due to the
economic impacts of COVID-19 in their workers compensation business. This was partially
offset by price increases and growth in other property and casualty lines; Brit reported
underwriting losses of $240 million and a combined ratio of 114%, which principally
reflected COVID-19 losses of $270 million or 15.8 combined ratio points and higher
catastrophe losses; Allied World reported an underwriting profit of $126 million, combined
ratio of 95.4%, an underwriting improvement over 2019 of $68 million; Fairfax Asia
reported an underwriting profit of $7 million and a combined ratio of 96.8%, which is
relatively consistent with their 2019 results; and finally, our Insurance and Reinsurance
Other segment produced an underwriting profit of $6 million and a combined ratio of
99.5% in 2020, which compared to an underwriting loss of $18 million and a combined
ratio of 101.7%.
Key components of our combined ratio in 2020 of 97.8% included the following, COVID19 losses of $669 million or 4.8 combined ratio points; increase in frequency of current
period cat loss events that resulted in higher losses at $644 million or 4.7 combined ratio
points primarily related to Hurricane Laura, Sally and the Midwest Derecho; benefit of
strong reserving reflected continued net favorable prior year reserve development of
$455 million or 3.3 combined ratio points; and improved underwriting expense ratios
reflecting the growth in our net premiums earned relative to the increases in the
underlying expenses.
Additional details on the catastrophe COVID-19 losses, net favorable prior year reserve
development and our combined ratios that impact each of the respective insurance and
reinsurance segments will be disclosed in Fairfax's 2020 annual report in the MD&A.
As noted in 2020, we reported COVID-19 losses of $669 million, which were comprised
primarily of business interruption exposure, approximately 35% primarily from our
international businesses and event cancellation coverage of approximately 34%. The
COVID-19 losses, principally comprised of incurred, but not reported that represented
Page 7 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

FINAL

51% of the net losses, and the net losses were primarily recorded at Brit $270 million,
Odyssey Group at $140 million and Allied World at $113 million.
Our catastrophe losses in 2020 of $644 million or 4.7 combined ratio points were
primarily comprised and reported by the following segments. Northbridge reported
CAD39 million or 2 combined ratio points primarily relating to Fort McMurray floods and
the Calgary hailstorms; Odyssey Group $190 million or 5.3 combined ratio points primarily
related to Hurricane Laura and the Midwest Derecho; Allied World $165 million or 6.1
combined ratio points related to Hurricane Laura, the U.S. Western wildfires and Midwest
Derecho; Crum & Forster, $95 million or 3.9 combined ratio points primarily related to
Hurricane Laura and Sally; and finally Brit $157 million or 9.2 combined ratio points primarily
related to Hurricane Laura and Sally. Our combined ratios benefited from net favorable
prior year reserve development of $455 million, which translated into 3.3 combined ratio
points compared to net favorable prior year reserve development of $480 million which
represented 3.8 combined ratio points in 2019.

Bloomberg Transcript

Looking at the growth in our net premiums written by the insurance and reinsurance
operations in the fourth quarter and full year 2020. In our fourth quarter 2020, the net
premiums written increased by 16.1% to $3.7 billion from $3.2 billion in the fourth quarter of
2019. And for the full year 2020, it increased by 11% to $14.7 billion from $13.3 billion in
2019. That full year increase in 2020 of approximately $1.5 billion is almost equivalent to all
of Northbridge's net premiums written in 2020.
And a few comments on a runoff operation. As noted in prior quarters subsequent to the
contribution of European run-off to Riverstone Barbados on March 31, 2020. Starting from
April 1, 2020, the operating results of run-off only include our U.S. operations. Excluding
this significant reinsurance transactions in Part VII transfer at European run-off in 2020 and
2019 run-off reported an operating loss of $204 million in 2020 compared to an operating
loss of $219 million in 2019, with run-off reporting an operating loss of $147 million in the
fourth quarter of 2020, principally reflecting net adverse prior year development on
asbestos reserves of $126 million.
Turning to the results of our non-insurance companies reporting segments. In 2020, the
restaurant and retail reporting segment reported an operating loss of $70 million, but in
the fourth quarter 2020, the company benefited from favorable results from this
segment that reported operating income of $12 million. This segment's revenues
benefited from expanded ecommerce platforms and strong brand awareness that
helped partially offset the decline in the in-store revenues throughout 2020 as a result of
the impact of COVID-19 lockdown restrictions.
The operating losses in the other non-insurance reporting segment of $54 million in 2020
principally reflected Fairfax Africa's operating losses of $110 million pre-deconsolidation on
December 8, 2020, partially offset by operating income at Dexterra and AGT.
On December 8, 2020, Fairfax Africa completed the transaction with Helios Holdings
Limited and was renamed Helios Fairfax Partners or HFP. Fairfax deconsolidated Fairfax
Africa and commenced accounting for its interest in HFP as an investment in associate,

Page 8 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

FINAL

resulting in a net loss of $62 million that included recycled foreign currency translation
losses of $27 million and those foreign currency translation losses have no impact on
common shareholders' equity, it's a reclassification in the financial statements. Also that
included the $62 million of partial reversal of the initial impairment loss of $164 million that
was recorded in the third quarter of 2020 related to an increase in the market-traded
share price at Fairfax Africa between then and closing.
Now looking at our results, our investment results for Fairfax, our consolidated interest in
dividend income decreased year-over-year from $880 million in 2019 to $769 million in
2020. That primarily reflected lower interest income earned principally on the U.S. treasury
bonds and cash, short-term positions that was partially offset by higher interest income
earned on our high quality U.S. corporate bonds.

Bloomberg Transcript

Our consolidated share of loss of associates of $113 principally reflected impairment
losses of $240 million that were recorded primarily in the first quarter of 2020 and were
related to the company's investments in Quess, Resolute, Atlas, Mara and Astarta. The
share of losses -- and it also included our share of loss of Sanmar of $49 million and
Bangalore Airport of $31 million, which was partially offset by profits at Atlas Corp. of $116
million and RiverStone Barbados of $113 million.
At December 31, 2020, our investments in associates had an aggregate fair value that
exceeded the carrying values by $712 million. And due to the equity method of accounting
for these investments, this excess of fair value over the carrying value is not included in
our book value per share. This is a significant positive change from the March 31, 2020,
when the aggregate carrying value exceeded the fair values of the investments in
associates by approximately $400 million. That represents on a pre-tax and noncontrolling interest basis appreciation of approximately $1.1 billion in these investment.
In terms of our net gains on investments, I'll highlight the fourth quarter and 2020 results.
In the fourth quarter, our consolidated net gain on investments was over $1.2 billion
compared to net gains on investments of $640 million in the fourth quarter of 2019. The
fourth quarter of 2020 principally reflected net gains on our long equity exposures, just
under $1.2 billion and net gains on our bonds of $112 million that was partially offset by $138
million on our short equity exposures which resulted in the closing of the company's
remaining short equity total return swaps.
And I remind you that in the first quarter of 2020, we reported net losses on investments
of just over $1.5 billion, and for fiscal year 2020, Fairfax's consolidated net gains on
investments was $313 million, a $1.8 billion swing within a year. Our consolidated net gains
on investments was $313 million, reflecting our net gains on bonds of $562 million,
primarily as a result of unrealized appreciation of high quality corporate bonds. And our
net gains on long equity exposures was $372 million which was partially offset by our short
equity exposure of $529 million that was fully closed out of the company's remaining short
equity total return swap position.
And in closing, a few comments on our financial position. Our total debt to total cap ratio,
excluding the company's consolidated non-insurance companies increased to 29.7% at

Page 9 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

FINAL

December 31, 2020 from 24.5% at December 31, 2019, primarily reflecting increased total
debt and decreased common shareholders' equity, principally related to the common
share dividend paid in Q1 and unrealized foreign currency translation losses, which was
partially offset by net earnings.
At December 31, 2020, our book value per share was $478 compared to $486 at
December 31, 2019 (Technical Difficulty) in the first quarter 2020 and an increase from the
third quarter of 2020 of 8.2%. The increase in book value per share in the fourth -- of 8.2%
in the fourth quarter of 2020 reflected Fairfax's core underwriting performance continuing
to be very strong with excellent investment returns.
And now Prem, I will pass it back over to you.

V. Prem Watsa

{BIO 1433188 <GO>}

(Technical Difficulty) your name and your company name and try to limit your questions to
only one so that's fair to everyone on the call. Okay, then we're ready for the questions.

Questions And Answers

Bloomberg Transcript

Operator
Thank you so much. We will now begin the question-and-answer session. (Operator
Instructions) Our first question comes from Jeff Fenwick from Cormark Securities. Your line
is now open. You may proceed.

Q - Jeff Fenwick

{BIO 15350794 <GO>}

Hi. Good morning, Prem.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Hey, good money, Jeff.

Q - Jeff Fenwick

{BIO 15350794 <GO>}

So, as you say, interesting time in the markets and good opportunities for stock pickers.
So my first question really is just around your general thoughts on investment rotation,
and are you being very active here and maybe selectively transmitting some positions and
looking for some new opportunities? And I guess the one I certainly get a lot of questions
on of late, not surprisingly, is BlackBerry. So any comments on, I guess, the allocation and
perhaps BlackBerry specifically?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Yeah, Jeff, just on BlackBerry, it's gone up and come down. So just a couple of points. First
of all, we don't comment on our securities' purchase or sales, you know that. I will just say
two points. One, there were insiders and have insider obligations on BlackBerry; and two,
BlackBerry closed at December 2020 -- closed the year at December '20 at (inaudible).
Page 10 of 21



FINAL

Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Having said that, in 2019, the technology stocks were doing very well and have been
doing very well for some time, as you know, Jeff, and the shift to value investing had
begun, and then COVID came at us in 2020 in March. And it was significant, 180 countries
closed down their economies, we didn't know what was going to happen and stocks -particularly value-oriented stocks or stocks companies sensitive to the economy crashed.
Since that time, we have come back, and now we've got vaccines coming in, we've got
testing, we just think the set to value investing will take place over time. And that's already
begun in November with the announcement of the Pfizer vaccine. Many, many vaccines
have come to play, countries are getting back to normalization. I don't know exactly when
but that will happen and the economies will come back.
And so we have constant stock pickers, we expect to make money on the things that
we've had invested it in the past, and we are constantly looking at better opportunities.
So this is what we've done for 35 years. We've got a tremendous track record. We've got
a very good investment team led by Wade Burton and Lawrence Chin, and very excited
Jeff about what will happen in the next few years.

Q - Jeff Fenwick

{BIO 15350794 <GO>}

Bloomberg Transcript

Okay. And maybe my next question, I'd like to just focus on capital and uses of capital.
Obviously, you highlighted, how the balance sheet has strengthened after your
RiverStone sale. As we look into this year with the insurance markets remaining hard, are
you thinking that your first priority, I guess is pushing more capital down into the operating
units. Are we looking at a similar magnitude of investment down there? I think it was $1.4
billion or maybe you might look more at doing something like share buybacks here for
stocks still trading below book value?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Yeah. So the first thing to say is that insurance is our business, core business. As you've
said we've put a ton of money in 2020 into the insurance companies. We don't think they
need any more money now, because our investment portfolios coming back up as
additional plus, but we've made them self financing at the end of the year. And we expect
them to grow significantly. When they grow, they grow over time, right. So when you write
premiums it kind of -- you earn it over more than a year as the year come forward.
So the insurance business is well growing that reminds me of 2001 and what happened in
2002 after September 11. Some differences, of course, at all times, but as we said prices
are going up. They're going up over -- all over the world and the terms are going up. We
have capital. We purposely did the 14% on Bit, so that we have another $375 million in
case we need it. But at the moment, we don't expect to need any money from the
holding company for our insurance companies. They're well capitalized and financed and
ready, and most importantly many companies are pulling back, Jeff, where our
management team who run the companies are ready to expand and are expanding
significantly as you saw in Allied and Northbridge and Odyssey already.

Q - Jeff Fenwick

{BIO 15350794 <GO>}

Page 11 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

And I guess maybe a comment on share buybacks then, if you have some capital available
for that?

FINAL

A - V. Prem Watsa

{BIO 1433188 <GO>}

Yeah. So share buybacks is always our first financing soundness, first, a good opportunity
to simplify our insurance companies; second is share buybacks, and that's what we always
look at. We had this opportunity as we mentioned on the total return swap. It's an
investment that we made. I've said before many a time that our stock prices are incredibly
cheap for the record that we've had. We go through phases though, we're not looking at
every three months, every quarter we are up 10% to 5% that's not how we run our
company. But our long-term record is perhaps one of the better ones you'll see.
And so we think our stocks are cheap, so we've had a total -- when we looked at the
potential investments that were available to Fairfax, in our investment portfolios, Fairfax
was among the best, if not the best, and so we bought 1.4 million shares as we said in a
total return swap, and -- as an investment, we bought that as an investment. So we look at
all possibilities, Jeff, and see what the future will bring.

Q - Jeff Fenwick

{BIO 15350794 <GO>}

Okay. Thank you for that color. I'll re-queue.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Bloomberg Transcript

Thank you, Jeff. And next question, Dale.

Operator
The next question comes from the line of Junior Ra, Private Investor. Your line is now
open, sir. You may proceed.

Q - Junior Ra

{BIO 17627950 <GO>}

Good morning, Prem.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Good morning. Good morning.

Q - Junior Ra

{BIO 17627950 <GO>}

Congratulations on a wonderful quarter. I have two questions. So for the total credit
swaps, when is the expiry date for that? And during the reddit [ph] fiesta did you guys to
take advantage by hedging any of your investments?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Sorry, when you say the credit swap, do you mean these total return swaps or...

Page 12 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Q - Junior Ra

{BIO 17627950 <GO>}

The Fairfax -- yeah, yeah, total ones. Yeah, sorry.

A - V. Prem Watsa

{BIO 1433188 <GO>}

FINAL

Total return swaps. Yeah. They are on-year swaps, we've historically been able to extend
it for as long as we like.

Q - Junior Ra

{BIO 17627950 <GO>}

Okay, thanks. And on the reddit question, did you -- were you guys able to lock in any of
the gains by taking any kind of hedging? Or was there no opportunity, because it was just
a short period of time?

A - V. Prem Watsa

{BIO 1433188 <GO>}

So, as I said, right, I made the point that on BlackBerry we're insider and we have insider
obligations, and we never talk about purchase or the sales of securities.

Q - Junior Ra

{BIO 17627950 <GO>}

Thanks.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Bloomberg Transcript

Thank you very much. Next question, Dale.

Operator
Our next question comes from the line of Tom MacKinnon from BMO Capital. Your line is
now open. You may proceed.

Q - Tom MacKinnon

{BIO 2430137 <GO>}

Yeah, thanks very much. Good morning, Prem.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Good morning.

Q - Tom MacKinnon

{BIO 2430137 <GO>}

My question is about the selling off 14% of Brit to OMERS. I mean, I think your reasoning
was we got $375 million as a result of that, and that's just in case we need it. Remember
earlier in 2020, you wanted the debt market, sort of, in case you need it. Why are you
selling off a 14% of Brit like in the height of some good hard markets here? Why would
you use debt (Multiple Speakers)?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Page 13 of 21



FINAL

Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Yeah. So very good question, Tom. We just want to be financially sound and we've got a
very good relationship with Brit and with OMERS. You know that we had 40% on
RiverStone U.K. that we sold to OMERS for $600 million. And so they're taking $225 million
and they are reinvesting $375 million in Brit. And now we just think we've got a very good
relationship. We bought back, Tom, I think we had about 89% OMERS out as in the past
and we had 89% before we did the 14%, or we bought all of it, I think, back in 2020, and
so we sold this 14% back. It's $375 million possible potential. We are going to refinance
some time off which we've always done on debt issues that are coming in the next three
years. We think it's just a good mix.

Q - Tom MacKinnon

{BIO 2430137 <GO>}

And so if anybody said you're selling off an insurance -- part of an insurance company in
what would appear to be pretty good insurance markets in order to improve liquidity
versus going to the debt market, how would you answer that question?

A - V. Prem Watsa

{BIO 1433188 <GO>}

I would answer that by saying that we've done this before, and we have the ability to
buyback that 14% from OMERS. We've got many targets that we can buy it in a year, in two
years or three years. So it gives us a lot of flexibility, Tom. And the debt markets are bad,
we understand that.

Q - Tom MacKinnon

{BIO 2430137 <GO>}

Bloomberg Transcript

Yeah. Okay. Thanks for that.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Thank you very much, Tom. And next question, Dale.

Operator
The next question comes from the line of Mark Dwelle from RBC Capital Markets. Sir, your
line is now open. You may proceed.

Q - Mark Dwelle

{BIO 4211726 <GO>}

Yeah, good morning. A couple of questions.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Good morning, Mark.

Q - Mark Dwelle

{BIO 4211726 <GO>}

Good morning. On the Barbados, the sale of the Barbados business, you had mentioned
briefly and it was mentioned in the press release about a plan to buyback or part of the
agreement requires the buyback of $1.2 billion of investment assets. Can you just
elaborate on that a little bit? Why is that being left out there? It seems like $1.2 billion is

Page 14 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

not an insignificant amount that presumably the holding company will need to come up
with within the next couple of years in order to fund that purchase.

FINAL

A - V. Prem Watsa

{BIO 1433188 <GO>}

So, Tom [ph], basically we had a stock portfolio in RiverStone U.K., and we could have sold
it in December or whenever in 2020. Our feeling was that it was very undervalued. So we
have the ability $1.2 billion is based on 2019 prices, year-end prices, or '22 we've got the
ability to sell it or buyback that just we think it will be -- right now the $1.2 billion is very
much what it's worth in the stock market meaning the stocks in that portfolio are very
much worth $1.2 billion. And we expected to do very well, and so we can sell it if we want
or we can hold it. And we just think value investing is coming to the fore. The companies
that we own are going to be -- are exceptionally undervalued in our minds. So I will take
that with a pinch of salt. But we think they are exceptionally valued, so exceptionally
undervalued, and we think they got to do very well. So we didn't want to sell that at these
prices, but that's basically (Multiple Speakers).

Q - Mark Dwelle

{BIO 4211726 <GO>}

So, these are primarily -- these are -- I'm sorry, these are common equities or these are
private equity holdings?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Bloomberg Transcript

No, these are predominantly common stock position that we have.

Q - Mark Dwelle

{BIO 4211726 <GO>}

Okay, thanks.

A - V. Prem Watsa

{BIO 1433188 <GO>}

We can sell them despite...

Q - Mark Dwelle

{BIO 4211726 <GO>}

Okay. My second question relates to executing the total return swap with respect to
Fairfax shares. I guess I was just curious why you pursue that structure rather than just
buying back the stock if you felt like that was the good opportunity? I mean, is this a
capital constraint that you couldn't really buyback that much?

A - V. Prem Watsa

{BIO 1433188 <GO>}

We'd have to be careful, right, so not so much. Yeah, we had to be very careful in terms
of how much we could buyback. When we looked at Fairfax as a stock price and looked at
everything else that we could buy, we just got total return swap on Fairfax. Right now we
paid $344 per share as you know U.S. dollars. Our book value is $478. I mean if you work
the math just on book value basis or -- we'd have about $200 million gain. If Fairfax stock
prices go to book value, it's worth another $200 million. We just think it's a terrific
investment and our total return swap structure was a very good way for us to do it, and so
we did it.
Page 15 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Q - Mark Dwelle

{BIO 4211726 <GO>}

FINAL

I don't want to disagree with you that it was a good strike price. I guess it was really the
format of transaction rather than just actually buying the shares using a derivative, instead
it's a little bit unusual. I have usually seen that with most of the companies that I have
followed. So that was really my main question.

A - V. Prem Watsa

{BIO 1433188 <GO>}

So, Mark, our point is just that we wanted to keep up -- we will have more than $1 billion in
cash in the holding company once -- almost it is done [ph], we will have $370 million -$375 million. We just wanted to be financially sound and -- in all ways as opposed to use
that cash at this point in time.

Q - Mark Dwelle

{BIO 4211726 <GO>}

Okay. Thanks for the answers and good luck for 2021.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Terrific. Thank you, Mark. Next question please, Dale.

Operator

Bloomberg Transcript

Thank you. The next question comes from Jaeme Gloyn from National Bank Financial. Your
line is now open. You may proceed.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Yeah. Hey, Jaeme.

Operator
I am so sorry. Jaeme has disappeared. Would you like to entertain other question?
(Operator Instructions)

A - V. Prem Watsa

{BIO 1433188 <GO>}

Dale, you want to go on to next question, please.

Operator
Sure. The next question comes from (inaudible). Your line is now open. You may proceed.

Q - Unidentified Participant
Hello, Prem.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Hi, Micheal [ph]. Can't hear you, Micheal.
Page 16 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Operator
Micheal line has got disconnected, or his line has disappeared. Would you like to entertain
Jaeme Gloyn?

FINAL

A - V. Prem Watsa

{BIO 1433188 <GO>}

Yeah, Dale, if you can't get them, go onto the next question, please.

Operator
Sure. Jaeme Gloyn, your line is now open. You may proceed.

Q - Jaeme Gloyn

{BIO 19737597 <GO>}

Yeah, good morning. Am I coming through?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Hey, good morning, Jaeme. Yeah, we can hear you well.

Q - Jaeme Gloyn

{BIO 19737597 <GO>}

Bloomberg Transcript

All right, okay. So first question is just around the Farmers Edge IPO that seems to be -that will be coming out pretty soon here. Can you maybe talk about some of the other
industries or companies that you're looking to maybe tap into this pretty robust IPO
market as a way to realize on value in some of those holding?

A - V. Prem Watsa

{BIO 1433188 <GO>}

You know, Jaeme, we are not allowed to say too much until they file, and until they have
done. So, Farmers Edge as you know has filed. We'll be filing some more. You'll be able to
guess them. And we will be filing them in India, in Fairfax India. Many of them there and
we've got some really good companies and we've developed them over time. And
Dexterra as a classic where the old Horizon North is called Dexterra. We have 49%. And
we expect that to be a very successful company over time.
So we have many of them. And when you look at our non-insurance companies, some of
you analysts are worried about the fact that we don't make any money, we reflect the
losses. But we don't show the gains. The gains come over time. So when you look at our
investment portfolio, you know this Jaeme, we've got common shares. We have more
than 20% that they become associates. If you have a 40% interest or numbers like that in
the case of Thomas Cook 65%, then you have the consolidate it.
So in our annual report in 2020 -- after the 2020 annual report that will come out in a few
weeks, we're going to show it to you so that you can -- going to take another attempt to
show you our common stock positions. And there some of them are just common stock
and some are associated, some are consolidated, it gets a little confusing, but that's the
accounting IFRS, we have to follow the accounting rules. But we're going to show that to
you in a way that I think will be easier to understand. And over time, all of these
Page 17 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

investments, some do very well in a short period of time and some take longer and we've
just -- we're patient long-term investors.

FINAL

Q - Jaeme Gloyn

{BIO 19737597 <GO>}

Okay, great. Thanks. And then just following up looking into the insurance sector as we
think about COVID-19 risks and losses and reserving there. Yeah, I would expect that loss
reserves would diminish as the vaccine rollout unfolds, but can you talk about maybe
some of the exposures in the event cancellation in business interruption...

A - V. Prem Watsa

{BIO 1433188 <GO>}

So, event -- yeah, event cancellation Jaeme, we've taken the next six months. You know
these event cancellation policies have been very few, if any we [ph] written after March
2020. And so we've looked at -- you know, Brit has looked forward and Allied World too,
and we basically written off the first six months, where we think there'll be a written. So we
don't expect it to be of any significance, but as I said in my comments that there was that
uncertainty, but we don't expect it to be very significant.

Q - Jaeme Gloyn

{BIO 19737597 <GO>}

Okay. And then on BI as well, do you have a quick comment to sort of frame that risk like
you just did with event cancellation?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Bloomberg Transcript

Which risk again, Jaeme, sorry?

Q - Jaeme Gloyn

{BIO 19737597 <GO>}

Business interruption.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Business interruption. Yeah, business interruption is an international risk that you have. So
it's outside North America. We've taken most of the hit. You'll see that, you know like
50%, 60% of the gross numbers that we've setup are IBNR, right. So that's a reserve that
are not allocated -- incurred, but not reported that we expected to come. We've been
conservative -- all through our history, we've been conservative, and so we expect that
even in the case of business interruption. Now there are some lawsuits and there is
regulatory bodies making decisions. So you have to watch how they come through, but
we think all in all, right now well reserved.

Q - Jaeme Gloyn

{BIO 19737597 <GO>}

Okay. That's great. Thank you.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Thank you, Jaeme. Yes, Dale, next question, please.

Page 18 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Operator
The next question comes from the line (inaudible), a private investor. Your line is now
open. One moment.

Bloomberg Transcript

FINAL

Q - Unidentified Participant
Long time and I followed you guys for a long time. And I believe that you know at this time
that you've stepped down from having primary investment responsibilities. I know that
Jamie manages some capital, Wade manages some capital. We all know that those are
very small portions of the capital base. And I think you were always quoting your long-term
track record, but I know when the man is out of tune with the markets, and I also think that
it was a huge mistake if you did not take the BlackBerry gift that was given to you by the
market. And I also don't think that you're doing deep analysis under holdings. I suspect
that you probably don't do a lot of diving into the financials, the statements, you probably
don't understand the microeconomics of the business you are sort of buying. You
probably are not talking to customers, suppliers, competitors, former employees, the
competitive -- the investment business is a very competitive business. It's not like it's used
to be. I'm not saying that you should go out and buy technology stocks, but I sense when
a man is not competitive in the field and is not working hard. And I think it's time that you
step down from primary investing. And I'm sure many of your associates agree with you,
but -- because they are Canadian and tend to be nicer than Americans. They just don't
say anything. And the banks don't ask you difficult questions because there are so few
good companies in Canada and they get financing fees from you, so they are scared of
the questions. Thank you.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Good. Good points. You're entitled to your opinion and we'll let time decide that, okay. So
thank you very much for your comment. Next question, Dale.

Operator
The next question comes from the line of (inaudible), private investor. Your line is now
open.

Q - Unidentified Participant
Hi, Prem, thanks for taking my question. My question is regarding Fairfax India. Could you
please provide an update on your investment in Bangalore Airport? Are you still bullish
about the prospects of that investment given the situation with COVID and/or it's going to
evolve in the next two, three years? And also could you provide an update regarding the
deal you had with OMERS to sell a stake at $2.7 billion valuation? And can we expect to like
has it closed or like could you provide an update there? And also could you tell us like
whether we are still looking to do the IPO as it was written in the last annual report by the
end of this year?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Page 19 of 21



FINAL

Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

Yeah. So, Bangalore International Airport is a world-class airport, doing very well. They
stopped of course during COVID. The business is coming back significantly. Passengers
are -- yeah, it's running at about 60% of capacity. And so the terminal is delayed, but in
2022, the second terminal will be built. The second runway is already built. And we expect
it to -- we are as excited about Bangalore International Airport as we always were. And
we've got a terrific guy running it, as you know, Hari Marar, and so this company will be on
its way in terms of its -- in terms of Fairfax India, it's a tremendous opportunity. India is a
land of opportunity, it's become very business-friendly. And Mr. Modi has come up with a
very good budget. And we expect that our anchorage over time will take it public. We
think $2.7 billion, $2.8 billion for Bangalore International Airport in 100% basis now is a very
reasonable price, and so that's very, very possible.
In terms of the anchorage approval, there is still -- India, there is a lot of approvals
necessary [ph] -- one more approval that is necessary and we think it will come soon. And
so as it's excited (inaudible) are in terms of Fairfax India and this got lots of possibilities.
With that, Dale, let me take the last question, if you don't mind.

Q - Unidentified Participant
Thank you.

Operator

Bloomberg Transcript

Sure. The next question comes from the line of Alan Parsow from Elkhorn Partners.

Q - Alan Parsow

{BIO 1446024 <GO>}

Thank you very much for taking the call.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Hey, Alan.

Q - Alan Parsow

{BIO 1446024 <GO>}

I just need a little bit of clarification if I can on the questions regarding BlackBerry. I
understand that you don't discuss changes in portfolio, et cetera, regarding any of your
positions. But there were filings made, and this goes with regard to your inside comments
-- insider comments and directorship. There were some filings made in January where six
of the Hamblin Watsa Fairfax team sold their entire positions in BlackBerry. I understand,
that's a subsequent event to the end of the quarter, but can you explain how they're able
to sell their shares and Fairfax may not be able to sell theirs? Or in the past, you've had -you have two different positions in BlackBerry, one convertible bonds and common stock.
Are you saying you have restrictions on both of those for clarification for me, please?

A - V. Prem Watsa

{BIO 1433188 <GO>}

Yeah. So the securities as you see doesn't distinguish between convertibles and common
shares. And in the case here, we are an insider, I am an insider and Fairfax is an insider. But
Page 20 of 21



Company N ame: Fairfax Financial H oldings L td
Company Ticker: FFH CN Equity
Date: 2021-02-12

some of the people may not be insiders, and I don't know who you're referring to Alan,
but some of them may not be insiders and so they can do what they want.

Q - Alan Parsow

{BIO 1446024 <GO>}

FINAL

As an example, Wade Burton, Roger Lace, I mean they were significant investor people.

A - V. Prem Watsa

{BIO 1433188 <GO>}

Yeah. No, that's right. But the company is an insider versus -- so we follow all these rules
very carefully. And no one can sell anything unless they go through our legal department.
And so we're very, very careful, Alan, in this type of situation, and we just -- we don't talk
about individual securities till we're done that just how we run our affairs for 35 years. And
so you will have to bear with us, Alan.
And I thank you for your question. I thank all of you. Dale, I think we're ready to go on to
end the call. And as we have announced previously for your safety and for the safety of all
our employees from the global pandemic, our annual meeting will once again be held
virtually on April 15, at which time I look forward to answering again all your questions.
Instructions on how to join that webcast will be published on our website soon. So Dale,
thank you very much. This will terminate the call. Thank you.

Operator

Bloomberg Transcript

And that concludes today's conference. Thank you all for participating. You may now
disconnect.

This transcript may not be 100 percent accurate and may contain misspellings and other
inaccuracies. This transcript is provided "as is", without express or implied warranties of
any kind. Bloomberg retains all rights to this transcript and provides it solely for your
personal, non-commercial use. Bloomberg, its suppliers and third-party agents shall
have no liability for errors in this transcript or for lost profits, losses, or direct, indirect,
incidental, consequential, special or punitive damages in connection with the
furnishing, performance or use of such transcript. Neither the information nor any
opinion expressed in this transcript constitutes a solicitation of the purchase or sale of
securities or commodities. Any opinion expressed in the transcript does not necessarily
reflect the views of Bloomberg LP.  COPYRIGHT 2022, BLOOMBERG LP. All rights
reserved. Any reproduction, redistribution or retransmission is expressly prohibited.

Page 21 of 21

